tiprankstipranks
Theravance Biopharma (TBPH)
NASDAQ:TBPH
Holding TBPH?
Track your performance easily

Theravance Biopharma (TBPH) Ownership - Who Owns Theravance Biopharma?

311 Followers

Theravance Biopharma (TBPH) Ownership Overview

27.16%7.96%0.79%9.85%54.24%
27.16% Insiders
0.79% Other Institutional Investors
9.85% ETFs
54.24% Public Companies and
Individual Investors
The ownership structure of Theravance Biopharma (TBPH) stock is a mix of institutional, retail, and individual investors. Approximately 18.60% of the company’s stock is owned by Institutional Investors, 27.16% is owned by Insiders, and 54.24% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 09, 2024
Eli Samaha
>10% Owner
xxxxxxxxxxxxx
$7798440
May 03, 2024
Eli Samaha
>10% Owner
xxxxxxxxxxxxx
$13117335

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$242180
Jun 30, 2024
xxxxxxxxxxxxx
$35616178

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,511,150Insider19.44%86,361,242
4,200,021Institution8.59%38,136,191
2,026,347Institution4.14%18,399,231
1,958,580Institution4.00%17,783,906
1,920,366Insider3.93%17,436,923
1,621,370Institution3.31%14,722,040
434,511Institution0.89%3,945,360
380,557Institution0.78%3,455,458
342,613Insider0.70%3,110,926
326,743Insider0.67%2,966,826

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,621,370Institution3.31%14,722,040
434,511Institution0.89%3,945,360
380,557Institution0.78%3,455,458
232,655Institution0.48%2,112,507
208,783Institution0.43%1,895,750
175,943Institution0.36%1,597,562
119,520Institution0.24%1,085,242
111,372Institution0.23%1,011,258
109,987Institution0.22%998,682
105,355Institution0.22%956,623

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,008,880Institution2.06%9,160,630
1,074,744Institution2.20%8,662,437
567,639Institution1.16%4,575,170
348,620Institution0.71%3,165,470
317,109Institution0.65%2,879,350
164,951Institution0.34%1,474,662
168,678Institution0.34%1,359,545
119,160Institution0.24%960,430
90,045Institution0.18%805,002
87,202Institution0.18%791,794

FAQ

Who Owns Theravance Biopharma (TBPH)?
According to the latest TipRanks data, approximately 0.79% of the company's stock is held by institutional investors, 27.16% is held by insiders, and 54.24% is held by retail investors.
    What percentage of Theravance Biopharma (TBPH) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.79% of Theravance Biopharma (TBPH) stock is held by institutional investors.
      What percentage of Theravance Biopharma (TBPH) stock is held by retail investors?
      According to the latest TipRanks data, approximately 54.24% of Theravance Biopharma (TBPH) stock is held by retail investors.
        Who owns the most shares of Theravance Biopharma (TBPH)?
        Eli Samaha owns the most shares of Theravance Biopharma (TBPH).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis